UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Randomized, Parallel, Open-Label Study to Compare Once-Daily Sevelamer Carbonate Powder Dosing With Thrice-Daily Sevelamer Hydrochloride Tablet Dosing in CKD Patients on Hemodialysis

American journal of kidney diseases, 2010-02, Vol.55 (2), p.307-315

2010

Volltextzugriff (PDF)

Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats

Behavioural brain research, 1999-07, Vol.102 (1), p.1-16

1999

Volltextzugriff (PDF)

Results of a Randomized Crossover Study Comparing Once-Daily and Thrice-Daily Sevelamer Dosing

American journal of kidney diseases, 2006-09, Vol.48 (3), p.437-444

2006

Volltextzugriff (PDF)

Novel Dosage Forms and Regimens for Sevelamer-Based Phosphate Binders

Journal of renal nutrition, 2006-07, Vol.16 (3), p.248-252

2006

Volltextzugriff (PDF)

Individual differences in the hotplate test and effects of habituation on sensitivity to morphine

Pain (Amsterdam), 1996-08, Vol.66 (2-3), p.265-270

1996

Volltextzugriff (PDF)

Sevelamer Hydrochloride (Renagel®), a Phosphate-Binding Polymer, Does Not Alter the Pharmacokinetics of Two Commonly Used Antihypertensives in Healthy Volunteers

Journal of clinical pharmacology, 2001-02, Vol.41 (2), p.199-205

2001

Volltextzugriff (PDF)

Rats with partial striatal dopamine depletions exhibit robust and long-lasting behavioral deficits in a simple fixed-ratio bar-pressing task

Behavioural brain research, 1997-06, Vol.86 (1), p.25-40

1997

Volltextzugriff (PDF)

Sevelamer, a phosphate-binding polymer, is a non-absorbed compound

Clinical pharmacokinetics, 2002, Vol.41 (7), p.517-523

2002

Volltextzugriff (PDF)

Chronic Morphine Reduces Pain-Related Disability in a Rodent Model of Chronic, Inflammatory Pain

Experimental and clinical psychopharmacology, 1999-08, Vol.7 (3), p.187-197

1999

Volltextzugriff (PDF)

The Analgesic Potential of Intraventricular Polymer-Encapsulated Adrenal Chromaffin Cells in a Rodent Model of Chronic Neuropathic Pain

Experimental and clinical psychopharmacology, 2000-11, Vol.8 (4), p.524-538

2000

Volltextzugriff (PDF)

Blind rats are not profoundly impaired in the reference memory Morris water maze and cannot be clearly discriminated from rats with cognitive deficits in the cued platform task

Brain research. Cognitive brain research, 1997-06, Vol.5 (4), p.329-333

1997

Volltextzugriff (PDF)

Somatic Delivery of Catecholamines in the Striatum Attenuate Parkinsonian Symptoms and Widen the Therapeutic Window of Oral Sinemet in Rats

Experimental neurology, 1997-05, Vol.145 (1), p.130-140

1997

Volltextzugriff (PDF)

Sevelamer, a phosphate-binding polymer, is a non-absorbed compound

Clinical pharmacokinetics, 2002, Vol.41 (7), p.517-523

2002

Volltextzugriff (PDF)

Dissociable long-term cognitive deficits after frontal versus sensorimotor cortical contusions

Journal of neurotrauma, 1998-03, Vol.15 (3), p.199-216

1998

Volltextzugriff (PDF)

The Safety and Pharmacokinetics of Deferitrin, a Novel Orally Available Iron Chelator

Blood, 2004-11, Vol.104 (11), p.504-504

2004

Volltextzugriff (PDF)

Pain-related disability and effects of chronic morphine in the adjuvant-induced arthritis model of chronic pain

Physiology & behavior, 1997-07, Vol.62 (1), p.199-205

1997

Volltextzugriff (PDF)

Validation of a rodent model of Parkinson's disease: Evidence of a therapeutic window for oral Sinemet

Brain research bulletin, 1996, Vol.39 (6), p.367-372

1996

Volltextzugriff (PDF)

Converting to Doxercalciferol Capsules From Intravenous Paricalcitol or Doxercalciferol

Journal of renal nutrition, 2012, Vol.22 (1), p.34-40.e2

2012

Volltextzugriff (PDF)

Intraventricular encapsulated calf adrenal chromaffin cells: viable for at least 500 days in vivo without detectable adverse effects on behavioral/cognitive function or host immune sensitization in rats

Restorative neurology and neuroscience, 1997, Vol.11 (1,2), p.21-35

1997

Volltextzugriff (PDF)

Short communication: Blind rats are not profoundly impaired in the reference memory Morris water maze and cannot be clearly discriminated from rats with cognitive deficits in the cued platform task

Brain research. Cognitive brain research, 1997-06, Vol.5 (4), p.329-333

1997

Volltextzugriff (PDF)

A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis

Nephrology, dialysis, transplantation, 2009-12, Vol.24 (12), p.3794-3799

2009

Volltextzugriff (PDF)

Sevelamer carbonate lowers serum phosphorus effectively in haemodialysis patients: a randomized, double-blind, placebo-controlled, dose-titration study

Nephrology, dialysis, transplantation, 2014-01, Vol.29 (1), p.152-160

2014

Volltextzugriff (PDF)

Preclinical and Clinical Development of Deferitrin, a Novel, Orally Available Iron Chelator

Annals of the New York Academy of Sciences, 2005-01, Vol.1054 (1), p.492-494

2005

Volltextzugriff (PDF)

Assessment of phosphate binding by sevelamer carbonate powder for oral suspension mixed in foods

Nephrology nursing journal : journal of the American Nephrology Nurses' Association, 2012-05, Vol.39 (3), p.239

2012

Volltextzugriff (PDF)

Sevelamer Hydrochloride (Renagel®), a Nonabsorbed Phosphate-Binding Polymer, Does Not Interfere with Digoxin or Warfarin Pharmacokinetics

Journal of clinical pharmacology, 2001-02, Vol.41 (2), p.193-198

2001

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Male
(20)
Biological And Medical Sciences
(15)
Animals
(14)
Humans
(13)
Medical Sciences
(13)
Rats
(13)
Sevelamer
(10)
Neurosciences
(9)
Neurosciences & Neurology
(9)
Rats, Sprague-Dawley
(9)
Female
(8)
Urology & Nephrology
(8)
Middle Aged
(7)
Adult
(6)
Aged
(6)
Pharmacology. Drug Treatments
(6)
Polyamines - Administration & Dosage
(6)
Renal Dialysis
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Randomized, Parallel, Open-Label Study to Compare Once-Daily Sevelamer Carbonate Powder Dosing With Thrice-Daily Sevelamer Hydrochloride Tablet Dosing in CKD Patients on Hemodialysis

Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats

Results of a Randomized Crossover Study Comparing Once-Daily and Thrice-Daily Sevelamer Dosing

Novel Dosage Forms and Regimens for Sevelamer-Based Phosphate Binders

Individual differences in the hotplate test and effects of habituation on sensitivity to morphine

Sevelamer Hydrochloride (Renagel®), a Phosphate-Binding Polymer, Does Not Alter the Pharmacokinetics of Two Commonly Used Antihypertensives in Healthy Volunteers

Rats with partial striatal dopamine depletions exhibit robust and long-lasting behavioral deficits in a simple fixed-ratio bar-pressing task

Sevelamer, a phosphate-binding polymer, is a non-absorbed compound

Chronic Morphine Reduces Pain-Related Disability in a Rodent Model of Chronic, Inflammatory Pain

The Analgesic Potential of Intraventricular Polymer-Encapsulated Adrenal Chromaffin Cells in a Rodent Model of Chronic Neuropathic Pain

Blind rats are not profoundly impaired in the reference memory Morris water maze and cannot be clearly discriminated from rats with cognitive deficits in the cued platform task

Somatic Delivery of Catecholamines in the Striatum Attenuate Parkinsonian Symptoms and Widen the Therapeutic Window of Oral Sinemet in Rats

Sevelamer, a phosphate-binding polymer, is a non-absorbed compound

Dissociable long-term cognitive deficits after frontal versus sensorimotor cortical contusions

The Safety and Pharmacokinetics of Deferitrin, a Novel Orally Available Iron Chelator

Pain-related disability and effects of chronic morphine in the adjuvant-induced arthritis model of chronic pain

Validation of a rodent model of Parkinson's disease: Evidence of a therapeutic window for oral Sinemet

Converting to Doxercalciferol Capsules From Intravenous Paricalcitol or Doxercalciferol

Intraventricular encapsulated calf adrenal chromaffin cells: viable for at least 500 days in vivo without detectable adverse effects on behavioral/cognitive function or host immune sensitization in rats

Short communication: Blind rats are not profoundly impaired in the reference memory Morris water maze and cannot be clearly discriminated from rats with cognitive deficits in the cued platform task

A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis

Sevelamer carbonate lowers serum phosphorus effectively in haemodialysis patients: a randomized, double-blind, placebo-controlled, dose-titration study

Preclinical and Clinical Development of Deferitrin, a Novel, Orally Available Iron Chelator

Assessment of phosphate binding by sevelamer carbonate powder for oral suspension mixed in foods

Sevelamer Hydrochloride (Renagel®), a Nonabsorbed Phosphate-Binding Polymer, Does Not Interfere with Digoxin or Warfarin Pharmacokinetics

Suchergebnisse filtern